Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-22T23:44:05.206Z Has data issue: false hasContentIssue false

Users' experiences of cathinones sold in head shops and online

Published online by Cambridge University Press:  13 June 2014

Fiona O'Reilly*
Affiliation:
Donabate, Co Dublin, Ireland
Ruardhi McAuliffe
Affiliation:
53 Parnell Square West, Dublin 1, Ireland. UISCE is an independent organisation that advocates for and promotes the well-being and rights of drug users, particularly those who are marginalised.
Jean Long
Affiliation:
Evidence Generation and Knowledge Brokering, Health Research Board, Knockmaun House, 42-47 Lower Mount Street, Dublin 2, Ireland.
*
*Correspondence Email: [email protected]

Abstract

Objective: We describe use and effects of head shop powders among opiate dependant polydrug users and recreational drug users. These powders contain cathinones and were sold as bath salts or plant food via the internet or in head shops.

Method: As this is a relatively new phenomenon, a qualitative approach using three data sources, in-depth interviews, a focus group (containing 10 opiate users) and a head shop website containing 49 product reviews, was employed. Themes were identified.

Results: According to the study population, these powders mimic the effects of cocaine, ecstasy and amphetamines. These substances were snorted, ingested or injected by people and were not used as bath salts or plant food. The users' experience indicates that these powders have the potential for dependence, and exhibit side effects such as insomnia, anxiety and other mental health effects. The users report that the effects of the substances vary over time indicating that the chemical contents of the powders may change.

Conclusion: Though users' descriptions of effects varied, there were indications of health and dependency effects which were more severe and more common among problematic opiate users, who also experienced increased social vulnerability. In general the recreational drug users considered their side effects to be mild and worth the drug induced experience.

Type
Brief report
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.DrAudrey, O'Donnell, Forensic Science Laboratory, Ireland; Dr Niamh Arthurs, Irish Medicines Board; Personal Communications, 2010Google Scholar
2.Kavanagh, P, McNamara, S, Mc Angelov, D, Dermott, S and Ryder, S (2010) Head shop legal highs' active constituents identification chart (May 2010, pre-ban). A modified version of this poster was presented atthe All Ireland Joint Schools of Pharmacy Research Seminar (March 2010) and at the launch of the Trinity Student Medical Journal (April 2010).Google Scholar
3.Krikorian, AD. Kat and its use: An historical perspective. Journal of Ethnopharmacology November 1984 Volume 12, Issue 2,: 115178CrossRefGoogle ScholarPubMed
4. Mephedrone: legal status. http://en.wikipedia.org/wiki/Mephedrone#Appearance Retrieved 18 March 2010Google Scholar
5.Department of Health and Children statement in relation to legislation to be made under Misuse of Drugs Act 1977 http://www.dohc.ie/press/releases/2010/20100511.htmlGoogle Scholar
6.MacNamara, S, Stokes, S and Coleman, N. (2010) Head shop compound abuse amongst attendees of The Drug Treatment Centre Board. Irish Medical Journal, 103 (5). http://www.imj.ie//ViewArticleDetails.aspx?ArticleID=5909Google Scholar
7. Merchants Quay Ireland and Anna Liffey Project, Personal communication, 2009 and Dr Brion Sweeney, Drug Treatment Centre Board, Personal communication, 2010Google Scholar
8.DrBrion, Sweeney, Drug Treatment Centre Board, Personal communication, 2010Google Scholar
9.DrNiamh, Arthurs, Irish Medicines Board, Personal Communication, 2009Google Scholar
10. Teenager dies of ‘net drug’ overdose http://www.thelocal.se/16366/20081215/ Published: 15 Dec 2008Google Scholar
11.What should be done about mephedrone? BMJ 2010;340:c1605CrossRefGoogle Scholar
13.DrAudrey, O'Donnell, Personal Communication, Forensic Science Laboratory, 2010.Google Scholar